Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations, including: Alkermes, Arrevus, Blueberry, Boehringer Ingelheim, Eli Lilly, Janssen, Jubilant, Regeneron, Sanofi and Surface